5p13 microduplication syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:329802OMIM:613174Q92.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

5p13 microduplication syndrome is a rare genetic condition caused by a small extra copy (duplication) of genetic material on the short arm of chromosome 5, specifically in the region known as 5p13. This syndrome is sometimes referred to as 5p13 duplication syndrome or trisomy 5p13. Because this region contains several important genes that guide early development, having extra copies of these genes can disrupt normal growth and brain development. People with this condition often experience developmental delays, intellectual disability that ranges from mild to moderate, speech and language difficulties, and distinctive facial features. Some individuals may also have behavioral challenges such as attention difficulties or features on the autism spectrum. Physical features can include a broad forehead, widely spaced eyes, a flat nasal bridge, and low-set ears, though these vary from person to person. Some children may have low muscle tone (hypotonia) and feeding difficulties in infancy. There is currently no cure for 5p13 microduplication syndrome. Treatment focuses on managing symptoms and supporting development through early intervention programs, speech therapy, occupational therapy, physical therapy, and special education services. With appropriate support, many individuals can make meaningful developmental progress. The condition is very rare, and ongoing research continues to improve our understanding of how it affects individuals over their lifetime.

Also known as:

Key symptoms:

Developmental delayIntellectual disability (mild to moderate)Speech and language delaysLow muscle tone (floppy muscles)Feeding difficulties in infancyDistinctive facial featuresBroad foreheadWidely spaced eyesFlat nasal bridgeBehavioral challengesAttention difficultiesAutism spectrum featuresShort statureLearning difficultiesMotor skill delays

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 5p13 microduplication syndrome.

View clinical trials →

No actively recruiting trials found for 5p13 microduplication syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 5p13 microduplication syndrome community →

No specialists are currently listed for 5p13 microduplication syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 5p13 microduplication syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 5p13 microduplication syndromeForum →

No community posts yet. Be the first to share your experience with 5p13 microduplication syndrome.

Start the conversation →

Latest news about 5p13 microduplication syndrome

No recent news articles for 5p13 microduplication syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the exact size and location of my child's duplication, and which genes are involved?,Was this duplication inherited from a parent or did it occur as a new event?,What developmental therapies should we start, and how often?,Are there any additional medical tests or screenings my child needs?,What should I expect in terms of my child's learning and development over time?,Should other family members be tested for this duplication?,Are there any research studies or registries we can participate in?

Common questions about 5p13 microduplication syndrome

What is 5p13 microduplication syndrome?

5p13 microduplication syndrome is a rare genetic condition caused by a small extra copy (duplication) of genetic material on the short arm of chromosome 5, specifically in the region known as 5p13. This syndrome is sometimes referred to as 5p13 duplication syndrome or trisomy 5p13. Because this region contains several important genes that guide early development, having extra copies of these genes can disrupt normal growth and brain development. People with this condition often experience developmental delays, intellectual disability that ranges from mild to moderate, speech and language diff

At what age does 5p13 microduplication syndrome typically begin?

Typical onset of 5p13 microduplication syndrome is infantile. Age of onset can vary across affected individuals.